Decimmune Therapeutics
Decimmune Therapeutics has not claimed their Profile.
Want to better differentiate Decimmune Therapeutics between your competitors? Show buyers how.
Why does Decimmune Therapeutics win vs. Dare Bioscience?
Show Decimmune Therapeutics's primary competitive advantage Show Decimmune Therapeutics's competitive differentiationDecimmune Therapeutics's alternatives and competitors
See how Decimmune Therapeutics compares to similar products. Decimmune Therapeutics's top competitors include Dare Bioscience, Iconic Therapeutics, and Endocyte.
Dare Bioscience is a healthcare company committed to the development and commercialization of innovative products in women's reproductive health. We believe there is an…
Decimmune Therapeutics vs. Dare Bioscience
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Iconic Therapeutics is a clinical-stage biopharmaceutical company dedicated to translating scientific knowledge into new medicines. The company's understanding of the r…
Decimmune Therapeutics vs. Iconic Therapeutics
View more in-depth data on:
- Competitors
- Products
- Customer References and more
- EN
Endocyte is a biotechnology company developing receptor-targeted therapeutics or smart drugs for the treatment of cancer and autoimmune diseases. The Company focuses on…
Decimmune Therapeutics vs. Endocyte
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Immutep, fka Prima BioMed, is a globally active leader in the development of personalized immunocellular therapeutic products for the treatment of cancer. Prima is dedi…
Decimmune Therapeutics vs. Immutep
View more in-depth data on:
- Competitors
- Products
- Customer References and more
REGiMMUNE is a biotechnology company focused on the discovery, development and commercialization of immune regulatory therapeutics to treat conditions such as allergies…
Decimmune Therapeutics vs. REGiMMUNE
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Regado Biosciences, a biopharmaceutical company, engages in the discovery and development of aptamer-based antidote-controlled therapeutics. The Company provides REG1 t…
Decimmune Therapeutics vs. Regado Biosciences
View more in-depth data on:
- Competitors
- Products
- Customer References and more
VLST (Viral Logic Systems Technology) has developed a streamlined and efficient platform that rapidly yields biological therapeutic compositions of matter with a far gr…
Decimmune Therapeutics vs. VLST Corporation
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Bayhill Therapeutics Inc. is a clinical-stage biotechnology company focused on developing and commercializing therapeutics that fundamentally alter the way autoimmune d…
Decimmune Therapeutics vs. Bayhill Therapeutics
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Alba Therapeutics Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutics to treat autoimmune, immune med…
Decimmune Therapeutics vs. Alba Therapeutics
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Metagenomix is an early-stage biotechnology company developing novel methods of screening microbes for pharmacologically active compounds.
Decimmune Therapeutics vs. Metagenomix
View more in-depth data on:
- Competitors
- Products
- Customer References and more
ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics to treat cancer and other diseases. At the core of the Company is the…
Decimmune Therapeutics vs. ARIUS Research
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Sangamo Therapeutics is focused on translating science into genomic medicines with the potential to transform patients' lives using the company's platform technologies …
Decimmune Therapeutics vs. Sangamo Therapeutics
View more in-depth data on:
- Competitors
- Products
- Customer References and more
- IN
Nata nel 2001, INCURA u00e8 una societu00e0 privata che unisce l'esperienza di validi ricercatori nell'ambito delle biotecnologie alla collaborazione con diversi Poli U…
Decimmune Therapeutics vs. InCura
View more in-depth data on:
- Competitors
- Products
- Customer References and more
EXT Life Sciences is a biotechnology company that genetically engineers the antioxidant enzyme catalase, using it to develop treatments that prevent, reduce or eliminat…
Decimmune Therapeutics vs. EXT Life Sciences
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Carigent Therapeutics is a biotechnology firm located in New Haven, CT dedicated to the development of next-generation therapeutic agents using a proprietary platform t…
Decimmune Therapeutics vs. Carigent Therapeutics
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Anagen Therapeutics is a biotechnology company focused on therapies for androgen and nuclear receptor-related diseases. Specific targets for its products under developm…
Decimmune Therapeutics vs. Anagen Therapeutics
View more in-depth data on:
- Competitors
- Products
- Customer References and more
Top 10 Decimmune Therapeutics competitors
You May Also Like
Stem Cells Bank Biotechnological Company engaged in development of autovaccines for treating oncological diseases and tuberculosis, produced on the basis of autologous dendritic cells (cells extracted from the organism of the very patient to be given the vaccine). In the framework of thus project it is planned to develop and launch a vaccine for treating oncological diseases and tuberculosis, produced on the basis of cells extracted from the organism of the very patient to be given the vaccine.
Dare Bioscience is a healthcare company committed to the development and commercialization of innovative products in women's reproductive health. We believe there is an unmet need globally for new product candidates that expand options, improve outcomes and are easy to use. By advancing these products, we seek to expand choices and to make a difference in the lives of women worldwide.
LeukoSight Inc. is an early stage biotechnology company developing a line of therapeutics that can be used to treat autoimmune and inflammatory diseases.
Moksha8 is a specialty pharmaceutical company focused on licensing, marketing and distributing established therapeutics in Brazil and Mexico.
Vybion is a developer and manufacturer of recombinant proteins for therapeutic and diagnostic applications. It uses its technologies along with a highly skilled staff to develop therapeutics, vaccines, diagnostics and bioavailability for pharmaceutical and biotechnology companies.
ASC is a privately held biotechnology company dedicated to the development and commercialization of enabling technologies to enhance and expand the therapeutic potential of stem cell therapies. The key technology platforms (ASC-101 and ASC-201) are designed to improve the homing and engraftment of stem cells to target organs and increase their therapeutic potential for cancer patients. Additionally, these platforms have the potential to enhance stem cell treatment of inflammation from chemotherapy/radiation, solid tumors, autoimmune diseases, and ischemic diseases including myocardial infarction and stroke. ASC has strategic partnerships with medical research institutions including the University of Texas M.D. Anderson Cancer Center, the Oklahoma Medical Research Foundation, University of California, the Burnham Institute, Indiana University, Rush Presbyterian and VidaCord Technologia Biomedica.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.